.Pharmacolibrary.Drugs.ATC.N.N05AH05_1 .Pharmacolibrary.Drugs.ATC.N.N05AH05_1| name: | Asenapine_1 |
| ATC code: | N05AH05_1 | route: | oral |
| n-compartments | 2 |
Asenapine is an atypical antipsychotic drug indicated for the treatment of schizophrenia and bipolar disorder. It acts as an antagonist at multiple serotonergic, dopaminergic, and adrenergic receptors. It is approved and currently used as a sublingual or transdermal medication.
Healthy adult subjects, oral (swallowed) administration, single dose for comparison
Dogterom, P, et al., & Troyer, MD (2018). Asenapine pharmacokinetics and tolerability in a pediatric population. Drug design, development and therapy 12 2677–2693. DOI:10.2147/DDDT.S171475 PUBMED:https://pubmed.ncbi.nlm.nih.gov/30214156
Rado, J, & Janicak, PG (2012). Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients. Drugs & aging 29(10) 783–791. DOI:10.1007/s40266-012-0009-0 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23018584